UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 17, 2006
Lifecore Biomedical, Inc.
(Exact name of Registrant as specified in its charter)
| | | | |
Minnesota | | 0-4136 | | 41-0948334 |
| | | | |
(State or other jurisdiction of incorporation or organization) | | (Commission File Number) | | (IRS Employer Identification No.) |
| | | | |
3515 Lyman Boulevard
| | |
Chaska, Minnesota
| | 55318 |
| | |
(Address of principal executive
| | (Zip Code) |
offices)
| | |
| | | | |
Registrant’s telephone number, including area code: 952-368-4300
|
TABLE OF CONTENTS
Item 2.02 Results of Operation and Financial Condition
On October 17, 2006, Lifecore Biomedical, Inc. (“Lifecore”) issued a press release setting forth Lifecore’s Fiscal 2007 first quarter financial results. A copy of Lifecore’s press release is attached hereto as Exhibit (99.1) and hereby incorporated by reference.
Item 9.01 Financial Statements and Exhibits
(c) The following exhibit is being furnished herewith:
99.1 Press release dated October 17, 2006
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | |
| LIFECORE BIOMEDICAL, INC. | |
Dated: October 17, 2006 | /s/ Dennis J. Allingham | |
| Dennis J. Allingham | |
| President & Chief Executive Officer | |
|
Exhibit Index
99.1 Press release dated October 17, 2006